1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
118.09%
Revenue growth above 1.5x 6247.T's 21.08%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
134.81%
Positive gross profit growth while 6247.T is negative. John Neff would see a clear operational edge over the competitor.
2047.84%
Positive EBIT growth while 6247.T is negative. John Neff might see a substantial edge in operational management.
810.34%
Positive operating income growth while 6247.T is negative. John Neff might view this as a competitive edge in operations.
929.47%
Positive net income growth while 6247.T is negative. John Neff might see a big relative performance advantage.
928.95%
Positive EPS growth while 6247.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
928.95%
Positive diluted EPS growth while 6247.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
37.71%
10Y revenue/share CAGR at 75-90% of 6247.T's 47.66%. Bill Ackman would press for new markets or product lines to narrow the gap.
56.91%
5Y revenue/share CAGR above 1.5x 6247.T's 21.85%. David Dodd would look for consistent product or market expansions fueling outperformance.
-35.67%
Negative 3Y CAGR while 6247.T stands at 8.47%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
53.14%
Below 50% of 6247.T's 122.46%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
87.56%
Positive 5Y CAGR while 6247.T is negative. John Neff might view this as a strong mid-term relative advantage.
-9.54%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
294.34%
10Y equity/share CAGR above 1.5x 6247.T's 46.17%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
56.00%
5Y equity/share CAGR above 1.5x 6247.T's 19.80%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
14.07%
3Y equity/share CAGR 1.25-1.5x 6247.T's 10.79%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
46.41%
AR growth well above 6247.T's 9.78%. Michael Burry fears inflated revenue or higher default risk in the near future.
-31.45%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-5.08%
Negative asset growth while 6247.T invests at 3.09%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
11.77%
BV/share growth above 1.5x 6247.T's 1.82%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-15.10%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-5.64%
Our R&D shrinks while 6247.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-23.73%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.